The pharmaceutical industry's increasing need for alumina trihydrate in the production of antacid medicines is projected to drive market expansion. Furthermore, increased demand for alumina trihydrate in water treatment applications where it works as flocculants in water purification is likely to drive market expansion. The pharmaceutical industry is increasingly using magnesium hydroxide as an alternative to alumina trihydrate in the manufacturing of antacid formulations because it efficiently decreases stomach acid and increases water in the gut. This aspect is projected to limit the expansion of the Alumina trihydrate market. In October 2018, the Fire-Retardant Additives (FRA) business section of J.M. Huber Corporation's Huber Engineered Materials (HEM) division announced its Fine Precipitated Hydrate (FPH) phase two capacity expansion project at the Martinswerk Plant. The fine precipitated alumina hydrate grades MARTINAL® LEO provide continuously exceptional processing qualities and serve as the company's worldwide product platform for its clients.
According to Coherent Market Insights, the global Alumina Trihydrate Market is estimated to account for approximately US$ 3,900 Mn in terms of value and 6,700 MT in terms of volume by the end of 2019.
Market Leaders in the Alumina Trihydrate Industry:
Alfa Aesar
Alfa Aesar, part of Thermo Fisher Scientific, is a leading manufacturer and supplier of chemicals, metals, and life science products for research and development. Alfa Aesar is a trusted, service-oriented company. Product quality is of paramount importance, but production expertise is just the beginning. Factors such as product availability, packaging and delivery are just as crucial to meeting and exceeding your expectations. Our established quality process ensures a high level of service and a promise of continually striving for perfection. With most catalog items in stock for same-day shipment, and a friendly and knowledgeable staff, we provide customers with an unsurpassed level of service. Founded in 1963, headquartered in ,Massachusetts, United States
Sumitomo Chemical Co. Ltd.
Sumitomo Chemical Co. Ltd. is a Japanese company that produces and markets various types of chemicals. The company’s business sectors include petrochemicals and plastics, energy and functional materials, IT-related chemicals, health and crop sciences, and pharmaceuticals. Its portfolio of products includes propylene oxide, caprolactam, polypropylene, polyethylene, methyl methacrylate polymer, alumina, aluminum, resorcinol, synthetic rubber, polarizing films, photoresists, super engineering plastics, lithium-ion secondary battery materials, crop protection chemicals, feed additives, products for control of infectious diseases, and more. The firm manages two companies in the pharmaceutical sector: Sumitomo Dainippon Pharma Co., Ltd., engaged in the prescription pharmaceuticals business; and Nihon Medi-Physics Co., Ltd., engaged in the diagnostic pharmaceuticals business. Sumitomo Chemical Co. Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.
